Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml in South Dakota
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Dakota
| Provider | Medicare | Services |
|---|---|---|
| White, David MD | $1.19 | 1.3K |
| Fujimoto, Jena M.D. | $1.23 | 1.3K |
| Kumar, Neil M.D. | $1.22 | 939 |
| Reher, Thomas M.D. | $1.21 | 864 |
South Dakota Pricing in Context
In South Dakota, CPT code A9579 (Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml) carries an average Medicare payment of $1.21 — 1% above the national benchmark of $1.20. 12 providers across the state submitted claims for this procedure in 2023, performing 6.9K total services. Individual payments in SD ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Dakota is $2.00, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Dakota sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in South Dakota lands near $3.12, with self-pay cash prices typically around $1.69. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml cost in South Dakota?
The average Medicare payment for Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml in South Dakota is $1.21, which is 1% above the national average of $1.20. Providers in SD typically bill $2.00 for this procedure.
What does Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml cost with insurance in South Dakota?
With commercial insurance in South Dakota, Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml costs an estimated $3.12. Without insurance, the estimated cash price is $1.69. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml in South Dakota?
12 providers in South Dakota billed Medicare for Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml in 2023, performing 6.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml cheaper in South Dakota than the national average?
No — Injection, Gadolinium-Based Magnetic Resonance Contrast Agent, Not Otherwise Specified (nos), Per Ml costs 1% above the national average in South Dakota. The state average Medicare payment is $1.21 compared to $1.20 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.